LLY vs JNJ stock comparison
ELI LILLY & Co vs. Johnson & Johnson · data as of November 13, 2026
ELI LILLY & Co (LLY) has a market value of about $1.36T, Johnson & Johnson (JNJ) about $687.9B. Over their latest twelve months ELI LILLY & Co had revenue of $86.5B and Johnson & Johnson $99.3B.
On our five checks ELI LILLY & Co scores higher: 3.4 out of 5 (good) against 2.6 (average).
By area, the stronger company is ELI LILLY & Co on future growth; ELI LILLY & Co on track record; Johnson & Johnson on financial health; Johnson & Johnson on shareholder returns.
Johnson & Johnson is cheaper on earnings (P/E 43.4 vs. 46.9), while ELI LILLY & Co grew revenue faster over five years (21.6% vs. 2.7% a year).
ELI LILLY & Co leads on 13 of the compared lines and Johnson & Johnson on 11.
Side by side
| LLY | JNJ | |
|---|---|---|
| Size and price | ||
| Market cap | $1.36T | $687.9B |
| Share price | $1,443.50 | $285.75 |
| Score | ||
| Overall score (of 5) | 3.4 | 2.6 |
| Value | 0 | 0 |
| Future growth | 5 | 0 |
| Track record | 5 | 4 |
| Financial health | 3 | 4 |
| Shareholder returns | 4 | 5 |
| Valuation | ||
| P/E (TTM) | 46.9 | 43.4 |
| Forward P/E | 30.4 | 25.1 |
| Price / free cash flow | 69.1 | 33.4 |
| Price / sales | 15.7 | 6.9 |
| EV / EBITDA | 37.1 | 26.7 |
| PEG | 1.70 | 2.91 |
| DCF value vs. price | −37% | −39% |
| Business | ||
| Revenue | $86.5B | $99.3B |
| Net income | $27.6B | $16.1B |
| Free cash flow | $19.7B | $20.6B |
| Net margin | 31.9% | 16.2% |
| Gross margin (5-yr avg.) | 78.9% | 69.1% |
| ROIC (5-yr avg.) | 22.9% | 16.6% |
| Growth | ||
| Revenue growth (1 yr) | 44.7% | 6.0% |
| Revenue growth (5 yrs, per year) | 21.6% | 2.7% |
| EPS growth (5 yrs, per year) | 27.6% | 14.9% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$44.6B | -$27.4B |
| Dividend yield | 0.48% | 1.88% |
| Shareholder yield | 0.8% | 2.8% |
| Analysts | ||
| Upside to average target | +1% | −2% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: LLY TTM to September 30, 2026, JNJ TTM to September 27, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, ELI LILLY & Co or Johnson & Johnson?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) ELI LILLY & Co scores 3.4 out of 5 and Johnson & Johnson 2.6; the table shows where each one is stronger.
Is ELI LILLY & Co cheaper than Johnson & Johnson?
On trailing earnings, Johnson & Johnson trades at a P/E of 43.4 and ELI LILLY & Co at 46.9, so Johnson & Johnson is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, ELI LILLY & Co or Johnson & Johnson?
Over five years ELI LILLY & Co grew revenue about 21.6% a year and Johnson & Johnson about 2.7% a year.
Which pays a higher dividend?
ELI LILLY & Co yields 0.48% and Johnson & Johnson 1.88%.
Full ELI LILLY & Co analysis → Full Johnson & Johnson analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.